Detalhe da pesquisa
1.
Experimental and computational modeling for signature and biomarker discovery of renal cell carcinoma progression.
Mol Cancer
; 20(1): 136, 2021 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34670568
2.
Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma.
N Engl J Med
; 379(5): 417-427, 2018 Aug 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29860937
3.
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma.
N Engl J Med
; 378(14): 1277-1290, 2018 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29562145
4.
The impact of sarcopenia on the efficacy and safety of immune checkpoint inhibitors in patients with solid tumours.
Acta Oncol
; 60(12): 1597-1603, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34549686
5.
Exploratory analysis of the platelet-to-lymphocyte ratio prognostic value in the adjuvant renal cell cancer setting.
Future Oncol
; 17(4): 403-409, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33028084
6.
Estimand framework: Are we asking the right questions? A case study in the solid tumor setting.
Pharm Stat
; 20(2): 324-334, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33155417
7.
Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial.
Lancet
; 393(10189): 2404-2415, 2019 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31079938
8.
Randomised Phase II study comparing alternating cycles of sunitinib and everolimus vs standard sequential administration in first-line metastatic renal carcinoma (SUNRISES study).
BJU Int
; 126(5): 559-567, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32654362
9.
Patient-reported outcomes in a phase 2 study comparing atezolizumab alone or with bevacizumab vs sunitinib in previously untreated metastatic renal cell carcinoma.
BJU Int
; 126(1): 73-82, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32233107
10.
Pharmacokinetics and safety of olaparib in patients with advanced solid tumours and mild or moderate hepatic impairment.
Br J Clin Pharmacol
; 86(9): 1807-1818, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32227355
11.
Long-term prognosis of septic shock in cancer patients.
Support Care Cancer
; 28(3): 1325-1333, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31243586
12.
Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial.
Lancet
; 391(10122): 748-757, 2018 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-29268948
13.
A Step Ahead in Metastatic Renal Cell Carcinoma.
N Engl J Med
; 384(14): 1360-1361, 2021 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33616313
14.
Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy.
N Engl J Med
; 375(23): 2246-2254, 2016 12 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27718781
15.
Renal cell carcinoma lung metastases treated by radiofrequency ablation integrated with systemic treatments: over 10 years of experience.
BMC Cancer
; 19(1): 1182, 2019 Dec 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31795959
16.
Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial.
Lancet Oncol
; 19(1): 51-64, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29217288
17.
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma.
N Engl J Med
; 373(19): 1803-13, 2015 Nov 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26406148
18.
Rheumatic disorders associated with immune checkpoint inhibitors in patients with cancer-clinical aspects and relationship with tumour response: a single-centre prospective cohort study.
Ann Rheum Dis
; 77(3): 393-398, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29146737
19.
Relationship between Pulmonary Adverse Events and Everolimus Exposure in Japanese and Non-Japanese Patients: A Meta-Analysis of Oncology Trials.
Oncology
; 92(5): 243-254, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28219073
20.
Metastatic non-muscle invasive bladder cancer with meningeal carcinomatosis: case report of an unexpected response.
BMC Cancer
; 17(1): 323, 2017 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28494780